Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Skin Laboratory PCLBKK:SKIN +3.53%20 Forward Dividend Yield % is 0.00% as of Aug. 19, 2026. GuruFocus rates BKK:SKIN with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,144 Consumer Packaged Goods companies, Skin Laboratory PCL ranks worse than 87412.5% on this metric.
As of today (2026-08-19), the Forward Annual Dividend Yield of Skin Laboratory PCL is 0.00%.
As of today (2026-08-19), the Trailing Annual Dividend Yield of Skin Laboratory PCL is 0.00%.
BKK:SKIN's Forward Dividend Yield % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 2.96 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Skin Laboratory PCL Forward Dividend Yield % Related Terms
BKK:SKIN vs PG, CL, KVUE: Forward Dividend Yield % Comparison
For the Household & Personal Products subindustry, Skin Laboratory PCL's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Skin Laboratory PCL Forward Dividend Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Skin Laboratory PCL's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Skin Laboratory PCL's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Skin Laboratory PCL (BKK:SKIN) has a Forward Dividend Yield % of 0.00% as of Aug. 19, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Skin Laboratory PCL and its competitors. According to the industry distribution chart, Skin Laboratory PCL ranks #999999 out of 1144 companies in the Consumer Packaged Goods industry.
Is Skin Laboratory PCL's Forward Dividend Yield % too high?
Skin Laboratory PCL's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Skin Laboratory PCL ranks #999999 out of 1144 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Skin Laboratory PCL has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Skin Laboratory PCL's Forward Dividend Yield % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Skin Laboratory PCL ranks #999999 out of 1144 companies for Forward Dividend Yield %. This places Skin Laboratory PCL in the lower half of its industry. The industry median Forward Dividend Yield % is 2.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Consumer Packaged Goods company?
The median Forward Dividend Yield % among Consumer Packaged Goods companies is 2.96, based on 1,144 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Skin Laboratory PCL and its competitors. For the Consumer Packaged Goods industry, the median Forward Dividend Yield % is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Skin Laboratory PCL's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Laboratory PCL stock overvalued right now?
Skin Laboratory PCL (BKK:SKIN) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Skin Laboratory PCL's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Skin Laboratory PCL (BKK:SKIN), the current Forward Dividend Yield % is 0.00% as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Skin Laboratory PCL is engaged in the business of inventing, developing, contracting production, and distributing beauty products under the Company's various brands, including facial serum products, sunscreen products, facial cleansers, facial care products, and other products. The Company's core business is only one operating segment, which is manufacturing and distributing skin creams, beauty creams, cosmetics, and operates virtually its business in one geographical location in Thailand.
20GF Score
Get the complete analysis for BKK:SKIN
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKIN has been successfully added to your 
